Publications by authors named "Kentaro Masuhiro"

Claim this Profile
S
Serum vesicle biomarkers reflect the disease activity of idiopathic pulmonary fibrosis.
Yuya Shirai, Takatoshi Enomoto, Yoshito Takeda, Ryuya Edahiro, Miho Takahashi-Itoh, Kentaro Masuhiro

J Transl Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential asthma biomarkers identified by nontargeted proteomics of extracellular vesicles in exhaled breath condensate.
Reina Hara, Yoshito Takeda, Takatoshi Enomoto, Hanako Yoshimura, Makoto Yamamoto, Kentaro Masuhiro

J Allergy Clin Immunol Glob· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum C-C motif chemokine ligand 17 as a predictive biomarker for the progression of non-idiopathic pulmonary fibrosis interstitial lung disease.
Takatoshi Enomoto, Yoshito Takeda, Yuya Shirai, Takehiro Hasegawa, Feng Zhao, Kentaro Masuhiro

Respir Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing the efficacy of near-infrared photoimmunotherapy through intratumoural delivery of CD44-targeting antibody-photoabsorber conjugates.
Yuichi Adachi, Kotaro Miyake, Kika Ohira, Shingo Satoh, Kentaro Masuhiro

EBioMedicine· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NHERF2 as a Novel Biomarker for Distinguishing MAC Pulmonary Disease from Tuberculosis Based on Proteome Analysis of Serum Extracellular Vesicles.
Maiko Naito, Yoshito Takeda, Ryuya Edahiro, Yuya Shirai, Takatoshi Enomoto, Kentaro Masuhiro

Int J Mol Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel and potent MICA/B antibody is therapeutically effective in mutant lung cancer models.
Ryan R Kowash, Manoj Sabnani, Laura T Gray, Qing Deng, Luc Girard, Kentaro Masuhiro

bioRxiv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SFTPB in serum extracellular vesicles as a biomarker of progressive pulmonary fibrosis.
Takatoshi Enomoto, Yuya Shirai, Yoshito Takeda, Ryuya Edahiro, Shigeyuki Shichino, Kentaro Masuhiro

JCI Insight· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galectin-10 in serum extracellular vesicles reflects asthma pathophysiology.
Hanako Yoshimura, Yoshito Takeda, Yuya Shirai, Makoto Yamamoto, Daisuke Nakatsubo, Kentaro Masuhiro

J Allergy Clin Immunol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Balloon Dilatation for Bronchoscope Delivery in a Swine Model: A Novel Technique for Ultra-Peripheral Lung Field Access and Accurate Biopsy.
Kotaro Miyake, Takayuki Shiroyama, Shingo Satoh, Yuichi Adachi, Kika Ohira, Kentaro Masuhiro

Respiration· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-associated SNRPD3 mutation confers resistance to hypoxia, which is attenuated by DRP1 inhibition.
Shingo Satoh, Kotaro Miyake, Yuichi Adachi, Kentaro Masuhiro, Shinji Futami

Biochem Biophys Res Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancer.
Takashi Hirai, Yujiro Naito, Shohei Koyama, Yoshimitsu Nakanishi, Kentaro Masuhiro

JCI Insight· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of the readthrough transcript CiDRE in alveolar macrophages boosts SARS-CoV-2 susceptibility and promotes COVID-19 severity.
Yuichi Mitsui, Tatsuya Suzuki, Kanako Kuniyoshi, Jun Inamo, Kensuke Yamaguchi, Kentaro Masuhiro

Immunity· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8 T cell cytotoxicity and proliferation.
Yujiro Naito, Shohei Koyama, Kentaro Masuhiro, Takashi Hirai, Takeshi Uenami

Sci Adv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebral Infarction Caused by Trousseau's Syndrome Associated With Lung Cancer.
Shoko Ikuta, Kanako Nishimatsu, Nao Shoshihara, Kentaro Masuhiro, Seigo Minami

World J Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposal of a novel pipeline involving precise bronchoscopy of distal peripheral pulmonary lesions for genetic testing.
So Takata, Kotaro Miyake, Daichi Maeda, Kazue Hatake, Izumi Nagatomo, Kentaro Masuhiro

Sci Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bronchoalveolar lavage fluid reveals factors contributing to the efficacy of PD-1 blockade in lung cancer.
Kentaro Masuhiro, Motohiro Tamiya, Kosuke Fujimoto, Shohei Koyama, Yujiro Naito

JCI Insight· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative evaluation of emphysema for predicting immunotherapy response in patients with advanced non-small-cell lung cancer.
Yoshimi Noda, Takayuki Shiroyama, Kentaro Masuhiro, Saori Amiya, Takatoshi Enomoto

Sci Rep· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leucine-rich a-2 glycoprotein as a potential biomarker of idiopathic multicentric Castleman disease with pulmonary involvement: a single-center case-control study from Japan.
So Takata, Yoshito Takeda, Haruhiko Hirata, Yuya Shirai, Takayoshi Morita, Kentaro Masuhiro

J Thorac Dis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood.
Yujiro Naito, Akio Osa, Kentaro Masuhiro, Takashi Hirai, Shohei Koyama

J Vis Exp· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unique Case of Pseudoprogression Manifesting as Lung Cavitation After Pembrolizumab Treatment.
Kentaro Masuhiro, Takayuki Shiroyama, Izumi Nagatomo, Atsushi Kumanogoh

J Thorac Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of successful concurrent anti-cancer treatment in a patient who developed follicular lymphoma during treatment with afatinib for advanced lung adenocarcinoma.
Kentaro Masuhiro, Genju Koh, So Takata, Shingo Nasu, Hiromune Takada

Respir Med Case Rep· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study.
Takayuki Shiroyama, Izumi Nagatomo, Shohei Koyama, Haruhiko Hirata, Sumiyuki Nishida, Kentaro Masuhiro

Sci Rep· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osimertinib Treatment Was Unsuccessful for Lung Adenocarcinoma with G719S, S768I, and T790M Mutations.
Shingo Nasu, Takayuki Shiroyama, Satomu Morita, So Takata, Hiromune Takada, Kentaro Masuhiro

Intern Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer.
Taro Koba, Seigo Minami, Yu Nishijima-Futami, Kentaro Masuhiro, Hiromi Kimura

Cancer Chemother Pharmacol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Pleural Effusion on Outcomes of Patients Receiving Osimertinib for NSCLC Harboring T790M.
Kentaro Masuhiro, Takayuki Shiroyama, Hidekazu Suzuki, S O Takata, Shingo Nasu

Anticancer Res· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis